The FDA review of the biologics license application includes data on SC isatuximab as both manual injection and via an ...

The EFFISAYIL ON study demonstrated that IV spesolimab may be an effective rescue therapy for GPP patients on SC spesolimab who experience a GPP flare.

Switching from IV to subcutaneous injection eases hard vein access, cuts clinic time, and boosts comfort with faster ...

Implementing subcutaneous opioid options in the emergency department significantly reduced reliance on intravenous administration.

Sikander Ailawadhi, MD, of the Mayo Clinic Florida in Jacksonville, discusses the clinical significance and primary outcomes ...

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024. In this segment, Dr. Morrison introduces the concept of ...

Since acquiring rare disease specialist Horizon Therapeutics in 2023 for $27.8 billion, Amgen has had difficulty boosting sales for the top product gained in the buyout, thyroid eye disease (TED) ...

Amgen said an injectable version of its blockbuster eye disease drug Tepezza hit both goals in a key late-stage trial that could help the company fend off competition from an emerging rival. According ...

Objectives The aim of this study was to investigate acute opioid dose changes among patients started on a continuous subcutaneous infusion (CSCI) containing alfentanil or morphine within a specialist ...

The primary selling point of this subcutaneous formulation of pembrolizumab has been improved convenience and efficiency for patients and health care systems. It has been described as allowing ...